Effects of ModifiedGuomin Decoction (加味过敏煎) on Traditional Chinese Medicine Syndromes and Quality of Life in Patients with Mild to Moderate Atopic Dermatitis of Heart Fire and Spleen Deficiency Pattern:A Randomized,Double-Blind,Placebo-Controlled Trial
|更新时间:2025-05-15
|
Effects of ModifiedGuomin Decoction (加味过敏煎) on Traditional Chinese Medicine Syndromes and Quality of Life in Patients with Mild to Moderate Atopic Dermatitis of Heart Fire and Spleen Deficiency Pattern:A Randomized,Double-Blind,Placebo-Controlled Trial
Journal of Traditional Chinese MedicineVol. 66, Issue 10, Pages: 1031-1037(2025)
NIE Jing,PANG Rui,QIAN Lingjiao,et al.Effects of Modified Guomin Decoction (加味过敏煎) on Traditional Chinese Medicine Syndromes and Quality of Life in Patients with Mild to Moderate Atopic Dermatitis of Heart Fire and Spleen Deficiency Pattern:A Randomized,Double-Blind,Placebo-Controlled Trial[J].Journal of Traditional Chinese Medicine,2025,66(10):1031-1037.
NIE Jing,PANG Rui,QIAN Lingjiao,et al.Effects of Modified Guomin Decoction (加味过敏煎) on Traditional Chinese Medicine Syndromes and Quality of Life in Patients with Mild to Moderate Atopic Dermatitis of Heart Fire and Spleen Deficiency Pattern:A Randomized,Double-Blind,Placebo-Controlled Trial[J].Journal of Traditional Chinese Medicine,2025,66(10):1031-1037.DOI: 10.13288/j.11-2166/r.2025.10.010.
Effects of ModifiedGuomin Decoction (加味过敏煎) on Traditional Chinese Medicine Syndromes and Quality of Life in Patients with Mild to Moderate Atopic Dermatitis of Heart Fire and Spleen Deficiency Pattern:A Randomized,Double-Blind,Placebo-Controlled Trial
(加味过敏煎, MGD) in patients with mild to moderate atopic dermatitis (AD) of the tradition
al Chinese medicine (TCM) pattern of heart fire and spleen deficiency, and to explore its possible mechanisms.
Methods
2
In this randomized, double-blind, placebo-controlled study, 72 patients with mild to moderate AD and the TCM pattern of heart fire and spleen deficiency were randomly divided into a treatment group and a control group, with 36 cases in each group. The treatment group received oral MGD granules combined with topical vitamin E emulsion, while the control group received oral placebo granules combined with topical vitamin E treatment. Both groups were treated twice daily for 4 weeks. Clinical efficacy, TCM syndrome scores, Visual Analogue Scale (VAS) for pruritus, Dermatology Life Quality Index (DLQI) scores, Scoring Atopic Dermatitis (SCORAD) and serum biomarkers, including interleukin-33 (IL-33), interleukin-1β (IL-1β), immunoglobulin E (IgE), and tumor necrosis factor-α (TNF-α) were compared before and after treatment. Safety indexes was also assessed.
Results
2
The total clinical effective rates were 77.78% (28/36) in the treatment group and 38.89% (14/36) in the control group, with cure rates of 19.44% (7/36) and 2.78% (1/36), respectively. The treatment group showed significantly better clinical outcomes compared to the control group (
P
<0.05). The treatment group exhibited significant reductions in total TCM syndrome scores, including erythema, edema, papules, scaling, lichenification, pruritus, irritability, insomnia, abdominal distension, and fatigue scores, as well as reductions in VAS, DLQI, SCORAD, and serum IgE and IL-33 levels (
P
<0.05 or
P
<0.01). Compared to the control group, the treatment group had significantly better improvements in all indicators except for insomnia (
P
<0.05). No adverse events occurred in either group.
Conclusion
2
MGD is effective and safe in treating mild to moderate AD patients with heart fire and spleen deficiency pattern. It significantly alleviates pruritus, improves TCM syndromes and quality of life, and enhances clinical efficacy, possibly through modulation of immune responses.
关键词
Keywords
references
TIAN J , ZHANG D , YANG Y , et al . Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study [J]. Br J Dermatol , 2023 , 190 ( 1 ): 55 - 61 .
GONZALEZ-URIBE V , VIDAURRI-DE LA CRUZ H , GOMEZ-NUNEZ A , et al . Comorbidities & burden of disease in atopic dermatitis [J]. Asian Pac J Allergy Immunol , 2023 , 41 ( 2 ): 97 - 105 .
SCHULER CF 4th , BILLI AC , MAVERAKIS E , et al . Novel insights into atopic dermatitis [J]. J Allergy Clin Immunol , 2023 , 151 ( 5 ): 1145 - 1154 .
STALDER JF , TAIEB A , ATHERTON DJ , et al . Severity scoring of atopic dermatitis: the SCORAD index.Consensus report of the European Task Force on Atopic Dermatitis [J]. Dermatology , 1993 , 186 ( 1 ): 23 - 31 .
REICH A , HEISIG M , PHAN NQ , et al . Visual analogue scale: evaluation of the instrument for the assessment of pruritus [J]. Acta Derm Venereol , 2012 , 92 ( 5 ): 497 - 501 .
FINLAY AY , KHAN GK . Dermatology Life Quality Index (DLQI):a simple practical measure for routine clinical use [J]. Clin Exp Dermatol , 1994 , 19 ( 3 ): 210 - 216 .
FACHERIS P , JEFFERY J , DEL DUCA E , et al . The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment [J]. Cell Mol Immunol , 2023 , 20 ( 5 ): 448 - 474 .
AAAAI/ACAAI JTF Atopic Dermatitis Guideline Panel . Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations [J]. Ann Allergy Asthma Immunol , 2024 , 132 ( 3 ): 274 - 312 .
AKDIS CA , ARKWRIGHT PD , BRUGGEN MC , et al . Type 2 immunity in the skin and lungs [J]. Allergy , 2020 , 75 ( 7 ): 1582 - 1605 .
MURAKAMI-SATSUTANI N , ITO T , NAKANISHI T , et al . IL-33 promotes the induction and maintenance of Th2 immune responses by enhancing the function of OX40 ligand [J]. Allergol Int , 2014 , 63 ( 3 ): 443 - 455 .
SCHULER CF 4th , GUDJONSSON JE . IL-33 antagonism does not improve chronic atopic dermatitis: what can we learn? [J]. J Allergy Clin Immunol , 2022 , 150 ( 6 ): 1410 - 1411 .
Effect of Heat-sensitive Moxibustion on Quality of Life and Immune Function in Non-Small Cell Lung Cancer Patients with Qi Deficiency and Phlegm Stasis Syndrome Undergoing Chemotherapy:A Randomized Controlled Trial
Effect of Modified Lurong Sancao Decoction (鹿蓉三草汤) on Quality of Life and Immune Function in Differentiated Thyroid Cancer Patients after Surgery:A Randomized Controlled Trial
Clinical Observation on Juanyin Decoction Combined with Pleural Chemotherapy and Radiofrequency Hyperthermia for 36 Cases of Malignant Pleural Effusion
Effects of Baduanjin on 42 Cases of Cancer-related Fatigue and Quality of Life in the Patients with Postoperative Rehabilitation of Gastrointestinal Malignant Tumors
Impact of Modified Shugan Yishen Fang(疏肝益肾方) Combined with Radiotherapy and Chemotherapy on Immune Regulation and Quality of Life of Patients with Triple Negative Breast Cancer
Related Author
ZHAN Wenhao
DING Qian
DONG Zhiwei
LI Ting
FU Shumei
TIAN Ning
YUAN Ming
YANG Fan
Related Institution
Guangdong Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Guangzhou University of Chinese Medicine
Jinan Vocational College of Nurisng,Shandong Pronvince
The First Affiliated Hospital of Shihezi University